(Q35632136)

English

Structure-based design and synthesis of covalent-reversible inhibitors to overcome drug resistance in EGFR.

scientific article published on 23 April 2015

In more languages

default values for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25975640

retrieved

9 August 2017

title

Structure-based design and synthesis of covalent-reversible inhibitors to overcome drug resistance in EGFR. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9 August 2017

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25975640

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975640%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 June 2020

author name string

Debjit Basu

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25975640

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975640%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 June 2020

André Richters

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25975640

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975640%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 June 2020

language of work or name

English

0 references

publication date

23 April 2015

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25975640

retrieved

9 August 2017

published in

Bioorganic & Medicinal Chemistry

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25975640

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975640%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 June 2020

volume

23

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25975640

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975640%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 June 2020

issue

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25975640

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975640%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 June 2020

page(s)

2767-2780

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25975640

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975640%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 June 2020

Identifiers

DOI

10.1016/J.BMC.2015.04.038

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25975640

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975640%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 June 2020

PubMed publication ID

25975640

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25975640

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975640%20AND%20SRC:MED&resulttype=core&format=json

(Q35632136)

Structure-based design and synthesis of covalent-reversible inhibitors to overcome drug resistance in EGFR.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)